Introduction to a Broken System

The United States health‑care industry is described as “incredibly broken.” Spending is nearly double that of other advanced economies, yet outcomes lag behind: life expectancy is lower, infant mortality is higher, and preventable deaths are more common. Many Americans postpone care because of stress and cost, raising the question of whether the system can be fixed without destroying the broader economy.

Economic Scale and Impact

Health‑care dominates U.S. consumer spending, inflating the nation’s gross domestic product. When health‑care is excluded, overall spending aligns with other developed countries. Analysts estimate that dismantling the current system could shave up to 10 % off U.S. GDP. This spending supports millions of jobs and a substantial portion of the financial system, making any large‑scale reduction politically and socially fraught.

The Challenge of Reform

Reforming health‑care means confronting entrenched bureaucratic bloat, a problem even critics of socialized medicine acknowledge. Policymakers hesitate to preside over mass job losses, and the sheer size of the industry creates a “log jam” of conflicting interests. Nevertheless, the difficulty of change does not justify inaction.

Global Export of Issues

The U.S. model has been exported abroad, spreading its high‑cost, low‑outcome characteristics to other nations. This export potentially worsens health outcomes worldwide, as other countries adopt similar pricing structures and administrative complexities.

Stakeholder Analysis

Doctors

Physicians, especially specialists, graduate with substantial debt—median $25,000, but up to $400,000 for private‑college routes. High education costs and lost earnings create an expectation of salaries that are almost double those in other OECD nations. The American Medical Association (AMA) lobbies Congress to limit residency positions, deliberately restricting the supply of new doctors. The Association of American Medical Colleges (AAMC) projects a shortage of 139,000 physicians by 2033. The AMA also pushes for legal restrictions that keep many tasks—such as routine prescription approvals—within the physician’s domain, even when nurse practitioners or physician assistants could perform them. Doctors spend considerable time justifying prescriptions to insurers, a task that could be delegated to administrative staff but is instead passed on to patients as higher costs.

Hospitals and Consolidation

Hospital systems have merged into large, often private‑equity‑backed entities that dominate local markets. Private equity purchases regional practices, creating monopolies that limit patient choice. Regulators struggle to challenge these mergers because health‑care complexity obscures true costs. Consolidated systems can force insurers into “all or nothing” contracts, demanding coverage of every facility in the network or risking loss of essential services. This market power incentivizes the provision of unnecessary procedures.

Insurance Companies

Private insurers are major players but can be overpowered by dominant hospital systems. “All or nothing” contracts prevent insurers from forming narrower, potentially cheaper networks. The Specialty Society Relative Value Scale Update Committee (RUC), a 31‑physician panel skewed toward specialists, advises Medicare on service valuation. Its recommendations set a price floor that ripples through the entire industry, inflating costs across the board.

Pharmaceutical Industry

Pharmaceutical firms generate roughly 40 % of their global revenue in the United States, even though the country represents only 4 % of the world’s population. High U.S. drug prices effectively subsidize research and development for the rest of the world. This profitability fuels the administrative bloat that forces doctors to spend time on insurance approvals rather than patient care.

Systemic Inefficiencies

Administrative costs per capita in the United States are more than three times those of Germany. Scope‑of‑practice restrictions, driven by AMA lobbying, keep many tasks out of the hands of qualified non‑physician providers, inflating demand for physician services. Doctors must justify routine prescriptions to insurers, a process that could be automated but is instead mandated by regulation, adding to patient expenses. Medicare pricing, shaped by the RUC’s specialist‑heavy recommendations, establishes a floor that sustains high fees throughout the health‑care market.

Market Failures in Health‑Care

Health‑care does not function as a normal market. Information asymmetry means payers (employers or insurers) differ from receivers (patients), while pricing remains opaque. In emergencies, patients cannot “shop around,” preventing competitive pressure from lowering costs.

Regulatory Capture and Lobbying

The health‑care sector is the top lobbying spender in the United States, disbursing nearly $0.75 billion at the federal level in 2024. This spending secures regulatory capture, allowing the industry to shape policies that preserve its size and profitability. The result is a self‑reinforcing bureaucracy that expands as it attempts to solve its own inefficiencies.

The Entrenched System

Over 20 million people are employed in the health‑care industry, yet fewer than one million are direct patient‑care physicians. The massive administrative workforce creates a “log jam” where each layer of bureaucracy generates additional layers, making dismantling the system exceedingly difficult.

Potential Solutions and Economic Trade‑offs

Proposals include stronger antitrust enforcement, lobbying reform, and greater price transparency. Replacing the U.S. model with a system similar to Australia’s could cut economic productivity by 7.5 % and cause millions of job losses—an impact larger than the 2008 financial crisis. Nonetheless, health‑care spending is projected to exceed one‑fifth of the U.S. economy by 2033, suggesting that without reform the economic burden will only grow. Even if some jobs disappear—such as internal auditors for investment banks that service health‑care deals—the long‑term benefit could be a healthier environment for entrepreneurship and higher birth rates, as families would face less fear of medical bankruptcy.